Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

被引:4945
作者
Vos, Theo [2 ]
Flaxman, Abraham D. [5 ]
Naghavi, Mohsen [5 ]
Lozano, Rafael [5 ]
Michaud, Catherine [8 ]
Ezzati, Majid [9 ]
Shibuya, Kenji [10 ]
Salomon, Joshua A. [12 ]
Abdalla, Safa
Aboyans, Victor [18 ]
Abraham, Jerry [19 ]
Ackerman, Ilana
Aggarwal, Rakesh [24 ]
Ahn, Stephanie Y. [5 ]
Ali, Mohammed K.
Alvarado, Miriam [5 ]
Anderson, H. Ross [27 ]
Anderson, Laurie M. [6 ]
Andrews, Kathryn G. [5 ]
Atkinson, Charles [5 ]
Baddour, Larry M. [28 ]
Bahalim, Adil N.
Barker-Collo, Suzanne [29 ]
Barrero, Lope H. [30 ]
Bartels, David H. [17 ]
Basanez, Maria-Gloria
Baxter, Amanda [1 ]
Bell, Michelle L. [31 ]
Benjamin, Emelia J.
Bennett, Derrick [33 ,34 ]
Bernabe, Eduardo [35 ]
Bhalla, Kavi [17 ]
Bhandari, Bishal
Bikbov, Boris [39 ]
Bin Abdulhak, Aref [40 ]
Birbeck, Gretchen [41 ]
Black, James A. [42 ]
Blencowe, Hannah [43 ]
Blore, Jed D. [2 ]
Blyth, Fiona
Bolliger, Ian [5 ]
Bonaventure, Audrey [48 ]
Boufous, Soufi Ane
Bourne, Rupert [51 ]
Boussinesq, Michel
Braithwaite, Tasanee [52 ]
Brayne, Carol [53 ]
Bridgett, Lisa
Brooker, Simon [43 ]
Brooks, Peter
机构
[1] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
[3] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia
[4] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia
[5] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA
[6] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA
[7] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA
[8] China Med Board, Boston, MA USA
[9] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England
[10] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan
[11] Harvard Univ, Dept Biostat, Boston, MA 02115 USA
[12] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[13] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA
[14] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA
[15] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA
[16] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA
[17] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA
[18] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France
[19] Univ Texas San Antonio, San Antonio, TX USA
[20] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia
[21] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[22] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia
[23] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia
[24] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India
[25] Emory Univ, Sch Publ Hlth, Atlanta, GA USA
[26] Emory Univ, Sch Med, Atlanta, GA USA
[27] St Georges Univ London, London, England
[28] Mayo Clin, Rochester, MN USA
[29] Univ Auckland, Auckland 1, New Zealand
[30] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia
[31] Yale Univ, New Haven, CT USA
[32] Boston Univ, Sch Med, Boston, MA 02118 USA
[33] Univ Oxford, Clin Trial Serv Unit, Oxford, England
[34] Univ Oxford, Epidemiol Studies Unit, Oxford, England
[35] Kings Coll London, Inst Dent, London WC2R 2LS, England
[36] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England
[37] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
[38] Queen Mary Univ London, Inst Dent, London, England
[39] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia
[40] King Fahad Med City, Riyadh, Saudi Arabia
[41] Michigan State Univ, E Lansing, MI 48824 USA
[42] MRC, Epidemiol Unit, Cambridge, England
[43] London Sch Hyg & Trop Med, London WC1, England
[44] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia
[45] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia
[46] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia
[47] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
[48] INSERM, Paris, France
[49] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[50] Univ New S Wales, Sydney, NSW, Australia
基金
瑞典研究理事会; 英国医学研究理事会; 澳大利亚国家健康与医学研究理事会; 英国惠康基金;
关键词
IRON-DEFICIENCY ANEMIA; DEPRESSIVE DISORDER; HEARING IMPAIRMENT; COGNITIVE FUNCTION; MENTAL-DISORDERS; LIFE EXPECTANCY; 187; COUNTRIES; PREVALENCE; HEALTH; POPULATION;
D O I
10.1016/S0140-6736(12)61729-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs). Methods Of the 291 diseases and injuries in the GBD cause list, 289 cause disability. For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality. Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies. For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources. For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates). Disability weights for 220 unique health states were used to capture the severity of health loss. YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods. We included uncertainty estimates at all stages of the analysis. Findings Global prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350 000 cases per 1 million people. Prevalence and severity of health loss were weakly correlated (correlation coefficient -0.37). In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990. The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases. The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls. Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010. Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality. Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa. Interpretation Rates of YLDs per 100 000 people have remained largely constant over time but rise steadily with age. Population growth and ageing have increased YLD numbers and crude rates over the past two decades. Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased. Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality. Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges. Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.
引用
收藏
页码:2163 / 2196
页数:34
相关论文
共 109 条
[1]  
*AG HEALTHC RES QU, US MED EXP PAN SURV
[2]   FRAILTY, SICKNESS, AND DEATH - MODELS OF MORBIDITY AND MORTALITY IN HISTORICAL POPULATIONS [J].
ALTER, G ;
RILEY, JC .
POPULATION STUDIES-A JOURNAL OF DEMOGRAPHY, 1989, 43 (01) :25-45
[3]  
[Anonymous], WEEKL RET SERV ANN R
[4]  
[Anonymous], WEEKL RET SERV ANN R
[5]  
[Anonymous], WEEKL RET SERV ANN R
[6]  
[Anonymous], NAT AMB MED CAR SURV
[7]  
[Anonymous], WEEKL RET SERV ANN R
[8]  
[Anonymous], 2000, FORCE DSM 4 DSM 4 T, DOI 10.1176/dsm10.1176/appi.books.9780890420249.dsm-iv-tr
[9]  
[Anonymous], 2017, The World Health Report 2017. Leishmaniose. In
[10]  
[Anonymous], W INDIAN MED J